Avacta Group Plc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Avacta Group Plc with three other
companies in this sector in the United Kingdom:
Diurnal Group PLC
sales of £1.04 million [US$1.38 million]
of which 100%
Fusion Antibodies PLC
(£2.18 million [US$2.88 million]
Oxford Biodynamics PLC
(£907,000.00 [US$1.20 million]
Avacta Group Plc reported sales of £4.12 million (US$5.44 million)
July of 2019.
increase of 49.2%
versus 2018, when the company's sales were £2.76 million.
This was the fourth straight year of sales growth at Avacta Group Plc.